EBIT in H1 FY'24 was $59.8m including a impairment cost of $3.1m
EBIT excluding impairment in H1 FY'24 was therefore $62.9m
EBIT excluding impairment in H1 FY'25 is $76.7m a 21% increase on same period LY
A good EBIT result in a very competitive constrained consumer environment.
Cheers.....D
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.060(4.40%) |
Mkt cap ! $781.5M | |||
| Open | High | Low | Value | Volume |
| $1.36 | $1.36 | $1.30 | $5.887M | 4.469M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 319568 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 48287 | 38 |
View Market Depth
| Last trade - 15.58pm 18/06/2025 (20 minute delay) ? |
| AX1 (ASX) Chart |